Hugh O'Dowd - Aug 31, 2021 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
President
Signature
/s/ Hugh O'Dowd
Stock symbol
TXMD
Transactions as of
Aug 31, 2021
Transactions value $
$0
Form type
4
Date filed
8/31/2021, 05:30 PM
Previous filing
Aug 13, 2021
Next filing
Mar 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Performance Stock Units Award $0 +2.75M $0.00 2.75M Aug 31, 2021 Common Stock 2.75M $0.00 Direct F1
transaction TXMD Restricted Stock Units Award $0 +2.75M $0.00 2.75M Aug 31, 2021 Common Stock 2.75M $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The performance stock units (PSUs) vest on August 31, 2024 based on the market capitalization of the issuer, which will be tested annually over three years beginning August 31, 2022 and are subject to the continuous service of the reporting person with the issuer. The number of PSUs listed is the maximum number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and maximum number of PSUs, depending on the milestones achieved. Each PSU represents a contingent right to receive one share of common stock of the issuer.
F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning August 31, 2022, becoming fully vested on August 31, 2024, subject in each case to the continued service of the reporting person with the issuer.